Clinical tools for chemotherapy toxicity prediction and survival in geriatric cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical tools for chemotherapy toxicity prediction and survival in geriatric cancer patients

Published:2018-06-26 Issue:5 Volume:30 Page:266-279
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Voutsadakis Ioannis A.¹²³^ORCID

Affiliation:

1. Division of Medical Oncology, Sault Area Hospital, Sault Ste Marie, Ontario, Canada;

2. Department of Internal Medicine, Sault Area Hospital, Sault Ste Marie, Ontario, Canada;

3. Division of Clinical Sciences, Northern Ontario School of Medicine, Sudbury, Ontario, Canada

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2018.1475442

Reference44 articles.

1. Cancer treatment and survivorship statistics, 2016

2. Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: Final results of the DOGMES multicentre GINECO trial

3. Tolerance and benefits of treatment for elderly patients with limited small-cell lung cancer

4. Cytotoxic therapy for the elderly with metastatic breast cancer: A review on safety, pharmacokinetics and efficacy

5. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Presentation, Molecular Characteristics, Treatment, and Outcomes of Colorectal Cancer in Patients Older than 80 Years Old;Medicina;2023-08-29

2. An evaluation of the Index4 tool for chemotherapy toxicity prediction in cancer patients older than 70 years old;Scientific Reports;2023-01-19

3. Comparative efficacy and toxicity of immune checkpoint inhibitors in combination with or without chemotherapy treatment for advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis;Frontiers in Oncology;2022-11-24

4. The Efficacy and Safety of PD-1/PD-L1 Immunosuppressive Agents in Advanced Esophageal Cancer: A Meta-Analysis;Advances in Clinical Medicine;2022

5. Sulfasalazine, a potent suppressor of gastric cancer proliferation and metastasis by inhibition of xCT: Conventional drug in new use;Journal of Cellular and Molecular Medicine;2021-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3